Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.66−0.10 (-1.74%)
Close on Nov 13, 2026Market cap $491.12MP/E –Yield –
Valneva enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Valneva's enterprise value was $631.10M on Nov 11, 2026, against $567.96M a year earlier. Over the last 3 years it ranged from $339.97M to $2.76B, with a median of $760.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $631.10M | -20.8% |
| 2025 | Oct 31, 2025 | $796.41M | +39.4% |
| 2024 | Apr 30, 2024 | $571.22M | +28.2% |
| 2023 | Apr 28, 2023 | $445.60M | -15.1% |
| 2022 | Oct 31, 2022 | $524.76M | -77.7% |
| 2021 | Dec 31, 2021 | $2.35B | – |
See a number that looks wrong?